Position in NVAX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$39,633,424
+$7,900,343 QoQ
Shares Held
4,207,370
+7.9% QoQ
Ownership
2.55%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,870,628,057 across 520 Biotechnology names. NVAX ranks #98 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in NVAX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,633,424 | 4,207,370 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $31,733,081 | 3,898,413 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,007,289 | 3,721,323 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $32,877,194 | 3,792,064 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $23,740,623 | 3,768,353 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $24,127,290 | 3,764,008 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $29,407,866 | 3,657,695 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $44,236,435 | 3,502,489 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $40,490,857 | 3,198,330 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $12,369,368 | 2,587,734 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $11,028,033 | 2,297,507 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $13,473,473 | 1,860,977 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,950,534 | 1,743,006 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,680,892 | 1,252,654 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,276,944 | 1,096,979 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,950,422 | 1,041,232 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $52,592,112 | 1,022,596 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $73,605,736 | 999,399 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $140,662,131 | 983,170 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $198,378,048 | 956,915 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $187,411,981 | 882,728 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $200,892,749 | 1,108,007 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $106,861,036 | 958,309 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $97,408,383 | 899,016 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $74,987,911 | 899,675 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $8,366,678 | 616,103 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||